Search research articles
Contact Us
Filters
Showing results (51-60 of 196) with videos related to
Page
of 20
Sort By:
Journal of Neuro-Oncology
|
April 30, 2014
Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing
Betty Y S Kim, Wen Jiang, Jason Beiko, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
June 10, 2016
Impact of histopathological transformation and overall survival in patients with progressive anaplastic glioma
Allen L Ho, Matthew J Koch, Shota Tanaka, et al.
Acta Neuropathologica Communications
|
May 1, 2019
PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma
Shota Tanaka, Tracy T Batchelor, A John Iafrate, et al.
Seminars in Radiation Oncology
|
June 7, 2020
Repeat Radiation in the Brain: Managing Patients With Locally Recurrent Glioma
Daniel M Trifiletti, Timothy D Malouff, Susan L McGovern, et al.
Journal of Neuro-Oncology
|
December 12, 2018
Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups
Tareq A Juratli, Shilpa S Tummala, Angelika Riedl, et al.
International Journal of Cancer
|
August 13, 2017
Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models
Shinichi Esaki, Fares Nigim, Esther Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2024
Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma
Eric P Grewal, Leland G K Richardson, Jing Sun, et al.
Annals of Diagnostic Pathology
|
March 27, 2012
Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma
Aditya Raghunathan, Adriana Olar, Hannes Vogel, et al.
Journal of Neuro-Oncology
|
June 10, 2026
Comparison between molecular and histological IDH-wild-type glioblastoma and extensive subgroup analysis of IDH-wild-type astrocytic tumors without genomic glioblastoma-defining alterations
Anna M Seifert, Sven Richter, André Sagerer, et al.
Neuro-Oncology
|
December 24, 2021
ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma
Chengchen Hu, Kimberly Wang, Ceylan Damon, et al.
Page
of 20
Search research articles
Search
Showing results (51-60 of 196) with videos related to
Sort By:
Page
of 20
Journal of Neuro-Oncology
|
April 30, 2014
Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing
Betty Y S Kim, Wen Jiang, Jason Beiko, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
June 10, 2016
Impact of histopathological transformation and overall survival in patients with progressive anaplastic glioma
Allen L Ho, Matthew J Koch, Shota Tanaka, et al.
Acta Neuropathologica Communications
|
May 1, 2019
PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma
Shota Tanaka, Tracy T Batchelor, A John Iafrate, et al.
Seminars in Radiation Oncology
|
June 7, 2020
Repeat Radiation in the Brain: Managing Patients With Locally Recurrent Glioma
Daniel M Trifiletti, Timothy D Malouff, Susan L McGovern, et al.
Journal of Neuro-Oncology
|
December 12, 2018
Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups
Tareq A Juratli, Shilpa S Tummala, Angelika Riedl, et al.
International Journal of Cancer
|
August 13, 2017
Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models
Shinichi Esaki, Fares Nigim, Esther Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2024
Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma
Eric P Grewal, Leland G K Richardson, Jing Sun, et al.
Annals of Diagnostic Pathology
|
March 27, 2012
Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma
Aditya Raghunathan, Adriana Olar, Hannes Vogel, et al.
Journal of Neuro-Oncology
|
June 10, 2026
Comparison between molecular and histological IDH-wild-type glioblastoma and extensive subgroup analysis of IDH-wild-type astrocytic tumors without genomic glioblastoma-defining alterations
Anna M Seifert, Sven Richter, André Sagerer, et al.
Neuro-Oncology
|
December 24, 2021
ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma
Chengchen Hu, Kimberly Wang, Ceylan Damon, et al.
Page
of 20